The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
A wilcoxon‐type test for trend
Cuzick, J. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040112 · Cited by 1,900
Cytochrome P450 and Chemical Toxicology
Guengerich, F. P. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700079z · Cited by 1,725
NELSON, D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREISEN, R., GONZALEZ, F. J., COON, M. J., GUNSALUS, I. C., GOTOH, O., et al. (1993) · DNA and Cell Biology · doi:10.1089/dna.1993.12.1 · Cited by 1,655
Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263
Nelson, D. R., Zeldin, D. C., Hoffman, S. M., Maltais, L. J., Wain, H. M., & Nebert, D. W. (2004) · Pharmacogenetics · doi:10.1097/00008571-200401000-00001 · Cited by 1,027
The Cytochrome P450 Superfamily: Biochemistry, Evolution and Drug Metabolism in Humans
P.B. Danielson, B. S. P. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337054 · Cited by 772
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
Weltman, M. D., Farrell, G. C., Hall, P., Ingelman-Sundberg, M., & Liddle, C. (1998) · Hepatology · doi:10.1002/hep.510270121 · Cited by 614
Inhibition and induction of human cytochrome P450 enzymes: current status
Pelkonen, O., Turpeinen, M., Hakkola, J., Honkakoski, P., Hukkanen, J., & Raunio, H. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0332-8 · Cited by 569
Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients
VIDELA, L. A., RODRIGO, R., ORELLANA, M., FERNANDEZ, V., TAPIA, G., QUIÑONES, L., VARELA, N., CONTRERAS, J., LAZARTE, R., CSENDES, A., et al. (2004) · Clinical Science · doi:10.1042/cs20030285 · Cited by 515
Extrahepatic Metabolism of Drugs in Humans
Krishna, D. R., & Klotz, U. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199426020-00007 · Cited by 437
Targher, G., Bertolini, L., Rodella, S., Zoppini, G., Lippi, G., Day, C., & Muggeo, M. (2008) · Diabetologia · doi:10.1007/s00125-007-0897-4 · Cited by 383
CYP3A gene expression in human gut epithelium
Kolars, J. C., Lown, K. S., Schmiedlin-Ren, P., Ghosh, M., Fang, C., Wrighton, S. A., Merion, R. M., & Watkins, P. B. (1994) · Pharmacogenetics · doi:10.1097/00008571-199410000-00003 · Cited by 365
Chalasani, N., Deeg, M. A., & Crabb, D. W. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30159.x · Cited by 343
Guengerich, F. P., & Turvy, C. G. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23168-8 · Cited by 266
Liver disease selectively modulates cytochrome P450–mediated metabolism
FRYE, R., ZGHEIB, N., MATZKE, G., CHAVESGNECCO, D., RABINOVITZ, M., SHAIKH, O., & BRANCH, R. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.05.006 · Cited by 250
George, J., Murray, M., Byth, K., & Farrell, G. C. (1995) · Hepatology · doi:10.1002/hep.1840210121 · Cited by 227
Cytochrome P450 and Liver Diseases
Villeneuve, J.-P., & Pichette, V. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335531 · Cited by 215
Michaelis, U. R., Fisslthaler, B., Barbosa-Sicard, E., Falck, J. R., Fleming, I., & Busse, R. (2005) · Journal of Cell Science · doi:10.1242/jcs.02674 · Cited by 173
Polymorphisms of CYP2A6 and its practical consequences
Raunio, H., Rautio, A., Gullstén, H., & Pelkonen, O. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01500.x · Cited by 167
Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity
Peter Guengerich, F. (1994) · Toxicology Letters · doi:10.1016/0378-4274(94)90156-2 · Cited by 158
UDP Glucuronosyltransferase mRNA Levels in Human Liver Disease
Congiu, M. A., Mashford, M. L., Slavin, J., & Desmond, P. V. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.2.129 · Cited by 157
The epidemiology of fatty liver
Bellentani, S., Bedogni, G., Miglioli, L., & Tiribelli, C. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200411000-00002 · Cited by 144
The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease
Lown, K. S., Kolars, J. C., Turgeon, D. K., et al. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.17 · Cited by 130
George, J., Liddle, C., Murray, M. T., Byth, K., & Farrell, G. C. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)00515-n · Cited by 103
George, J. (1995) · Hepatology · doi:10.1016/0270-9139(95)90418-2 · Cited by 85
Yang, L., Li, S.-J., Cao, Y.-F., Man, X., Wei-feng, Y., Wang, H.-Y., & Wu, M.-C. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i2.359 · Cited by 73
Kirby, G. M., Batist, G., Alpert, L., Lamoureux, E., Cameron, R., & Alaoui‐Jamali, M. A. (1996) · Toxicologic Pathology · doi:10.1177/019262339602400408 · Cited by 67
Lucas, D., Berthou, F., Dréano, Y., Lozac'h, P., Volant, A., & Menez, J. F. (1993) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1993.tb00861.x · Cited by 60
Chtioui, H., Semela, D., Ledermann, M., Zimmermann, A., & Dufour, J. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01524.x · Cited by 59
Metabolic Syndrome Is Related to Nonalcoholic Steatohepatitis in Severely Obese Subjects
Huang, H., Lin, W., Lee, L., Wang, H.-H., Lee, W., & Huang, K. (2007) · Obesity Surgery · doi:10.1007/s11695-008-9423-0 · Cited by 49
Ohnishi, A., MURAKAMI, S., Akizuki, S., Mochizuki, J., Echizen, H., & Takagi, I. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005280787 · Cited by 47
Li, L., Chen, S., Zhang, Y., Yu, C., Li, S.-D., & Li, Y. (2006) · PubMed · Cited by 34
Zhou, M., Maitra, S. R., & Wang, P. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.4.423 · Cited by 31
Nichols, K. D., & Kirby, G. M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.09.009 · Cited by 27
Spectroscopic quantitation of cytochrome P‐450 in human lung microsomes
Wheeler, C. W., & Guenthner, T. M. (1990) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.2570050410 · Cited by 19
Caffeine metabolism in a group of 67 patients with primary biliary cirrhosis
Le-Louët, H., Bechtel, Y. C., Paintaud, G., Brientini, M. P., Miguet, J. P., & Bechtel, P. R. (2001) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp39025 · Cited by 16
Bechtel, Y. C., Haffen, É., Le-Louët, H., Brientini, M. P., Paintaud, G., Miguet, J. P., & Bechtel, P. R. (2000) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38467 · Cited by 15
Cited by
Cobbina, E., & Akhlaghi, F. (2017) · Drug Metabolism Reviews · doi:10.1080/03602532.2017.1293683 · Cited by 653
Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Uhlen, M., & Nielsen, J. (2014) · Nature Communications · doi:10.1038/ncomms4083 · Cited by 519
Impact of Obesity on Drug Metabolism and Elimination in Adults and Children
Brill, M. J. E., Diepstraten, J., van Rongen, A., van Kralingen, S., van den Anker, J. N., & Knibbe, C. A. J. (2012) · Clinical Pharmacokinetics · doi:10.2165/11599410-000000000-00000 · Cited by 382
Cave, M., Appana, S., Patel, M., Falkner, K. C., McClain, C. J., & Brock, G. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1002720 · Cited by 293
Nuclear receptors and nonalcoholic fatty liver disease
Cave, M. C., Clair, H. B., Hardesty, J. E., Falkner, K. C., Feng, W., Clark, B. J., Sidey, J., Shi, H., Aqel, B. A., McClain, C. J., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.03.002 · Cited by 279
Metadata
- Authors
- Fisher, C. D., Lickteig, A. J., Augustine, L. M., Ranger-Moore, J., Jackson, J. P., Ferguson, S. S., & Cherrington, N. J.
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 37
- Issue
- 10
- Pages
- 2087-2094
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2122742700
- Cited by
- 352
- References
- 38
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.